Selected article for: "cardiac disease and MMVD mitral valve disease"
Title: 2016 ACVIM Forum Research Abstract Program
  • Document date: 2016_5_31
    • ID: 2y1y8jpx_39
    Snippet: In conclusions, the mitral valve of dogs with MMVD loses the saddle shape as the mitral valve disease progresses. The results of this study suggested that as the severity of MMDV worsened, more mechanical stress would be placed on the mitral valve, which could increase the progression of mitral regurgitation. To the best of our knowledge, this is the first report about the morphological changes of mitral valve annulus according to disease severit.....
    Document: In conclusions, the mitral valve of dogs with MMVD loses the saddle shape as the mitral valve disease progresses. The results of this study suggested that as the severity of MMDV worsened, more mechanical stress would be placed on the mitral valve, which could increase the progression of mitral regurgitation. To the best of our knowledge, this is the first report about the morphological changes of mitral valve annulus according to disease severity in dogs with MMVD. Oxidative stress has been associated cardiovascular disease and suggested to contribute to cardiac remodeling in human patients with mitral regurgitation. Few previous studies have evaluated the relationship between oxidative stress and myxomatous mitral valve disease (MMVD) in dogs. The objective of this study was to determine plasma concentrations of certain markers of oxidative stress and investigate if they were associated with MMVD severity, selected clinical variables and disease progression in dogs with no or different severities of MMVD.

    Search related documents:
    Co phrase search for related documents
    • cardiac remodeling and mitral regurgitation: 1
    • cardiac remodeling and mitral valve: 1, 2, 3, 4, 5
    • cardiac remodeling and mitral valve disease: 1, 2, 3, 4
    • cardiovascular disease and clinical variable: 1, 2, 3, 4, 5
    • cardiovascular disease and different severity: 1, 2, 3, 4, 5, 6, 7, 8
    • cardiovascular disease and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and mechanical stress: 1
    • cardiovascular disease and mitral regurgitation: 1, 2
    • cardiovascular disease and mitral valve: 1, 2, 3, 4, 5, 6, 7
    • cardiovascular disease and mitral valve disease: 1, 2, 3, 4, 5
    • clinical variable and different severity: 1, 2
    • clinical variable and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • clinical variable and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • different severity and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • different severity and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • different severity and human patient: 1
    • disease progression and human patient: 1, 2, 3
    • disease progression and mitral regurgitation: 1, 2, 3